PROTACERalpha Degrader-12 is a potent and highly selective ERalpha PROTAC degrader. It exhibits antiproliferative effects on various wild-type and mutant ERalpha breast cancer cell lines, causing cell cycle arrest and inducing apoptosis. PROTACERalpha Degrader-12 demonstrates excellent antitumor and ERalpha degradation activity and is suitable for breast cancer research.
Target:
Estrogen Receptor/ERR|||Apoptosis|||PROTACs
* VAT and and shipping costs not included. Errors and price changes excepted
